The study, published in Frontiers in Acoustics by Sam Bleker and colleagues at HAWK University of Applied Sciences and Arts, the University Medical Center Göttingen, and the Medical Laser Center Lübeck, is notable less for a single dramatic number than for the unusual rigor of its temporal accounting. Rather than simply measuring how much tracer crossed a barrier after ultrasound exposure, the team measured transport during the sixty-second sonication window and again in the nine minutes that followed, treating these intervals as fundamentally different biological events. That distinction, they argue, has been missing from much of the in vitro literature.

The experimental system was deliberately reductionist. Human cerebral microvascular endothelial cells, the hCMEC/D3 line widely used as a workhorse model of the blood-brain barrier, were grown on ThinCert permeable inserts for six days until they formed continuous monolayers. Lucifer Yellow, a small hydrophilic fluorescent dye that normally crosses such barriers only slowly through paracellular routes, was placed in the donor compartment above the cells. The researchers then applied continuous-wave focused ultrasound at 1.2 megahertz and 80 volts peak-to-peak for exactly sixty seconds, with no microbubbles, no pulse modulation, and no amplitude ramping.

Characterizing the acoustic field proved to be its own challenge, and the team approached it with unusual candor. Using a calibrated PVDF hydrophone, they scanned frequencies from 0.1 to 2.0 megahertz and found that 1.2 megahertz produced the highest mean peak rarefactional pressure at the focal distance of 5.0 millimeters from the lens apex. Because direct measurement at the biological exposure voltage was not performed, they scaled pressures from the 100-volt calibration condition by a factor of 0.8, arriving at an estimated peak rarefactional focal pressure of 0.838 plus or minus 0.054 megapascals. The authors are explicit that this number describes the calibration geometry, not the actual pressure at the cell layer inside the well-and-insert system, where reflections, standing waves, and lateral spread can substantially reshape the field.

The central result was unambiguous in direction. Across eight independent paired experiments, each comparing an ultrasound-exposed monolayer with an unexposed control from the same culture preparation, the mean control-adjusted increase in Lucifer Yellow accumulation during the exposure interval was 0.283 nanomoles, with a 95 percent confidence interval of 0.185 to 0.380 nanomoles. All eight experiments showed the effect in the same direction, and the standardized effect size, Cohen’s dz of 2.43, was exceptionally large. After Holm correction for multiple comparisons, the p-value was 0.000475. Leave-one-experiment-out analyses confirmed that no single pair drove the result.

What happened next was equally informative. During the nine minutes after the ultrasound was switched off, the additional control-adjusted accumulation was only 0.035 nanomoles, with a confidence interval spanning zero and a Holm-adjusted p-value of 0.555. In other words, the transport enhancement was essentially confined to the period of active insonification. The cumulative difference at ten minutes remained positive, but the authors caution that this largely reflects tracer that crossed during exposure, not continued leakage afterward. They also stress that the absence of detectable post-exposure accumulation does not prove the barrier had fully recovered, since no formal equivalence test or later functional measurement was performed.

The viability data add a layer of caution. In five separate paired experiments, the team stained monolayers immediately after exposure with Calcein-AM and ethidium homodimer-1, standard live-dead indicators, and quantified four image-derived metrics using condition-independent segmentation thresholds. The results were mixed: some experiments showed apparent increases in certain metrics, others showed decreases, and no reproducible ultrasound-associated direction emerged. Standardized effect sizes were small, and the authors explicitly warn that these findings cannot establish biological safety or the absence of delayed or spatially heterogeneous injury, particularly given the small sample size and the lack of a deliberately damaged positive control.

Perhaps the most intriguing and least settled observation came from the cell-free experiments. In a preliminary session conducted before the cellular series, three paired comparisons of ultrasound-exposed and unexposed cell-free inserts, inserts coated with Matrigel but lacking cells, showed no comparable positive response during the exposure interval. All three paired differences were negative. This hints that the transport enhancement in the cellular experiments may depend on the presence of living endothelial cells rather than on ultrasound-driven convection through the membrane alone. But the authors are careful: because all three cell-free pairs came from a single session, they cannot reliably quantify or exclude non-cellular contributions, and independent replication would be needed to separate endothelial, membrane, and fluid-system effects.

What mechanism could explain the response? The authors decline to commit. Acoustic radiation force, oscillatory deformation of the cells, fluid motion, or local shear stress could activate mechanosensitive signaling pathways, alter cortical actin tension, or transiently reorganize cell-cell junctions. Membrane permeabilization or vesicular transport cannot be ruled out either. A thermal contribution is also possible, since the sixty-second continuous-wave exposure was delivered without temperature monitoring, and the liquids were not degassed. The absence of visible bubbles during exposure does not exclude microscopic cavitation, and no passive cavitation detection was performed. The study therefore establishes that something happened during insonification, but not precisely what.

The broader context makes the work more than a laboratory curiosity. Focused ultrasound combined with intravenously administered microbubbles has already progressed from preclinical studies to early clinical trials for temporarily opening the blood-brain barrier in conditions such as Alzheimer’s disease and amyotrophic lateral sclerosis. Rodent studies have also demonstrated targeted and reversible opening of the blood-retinal barrier. But those approaches depend on circulating microbubbles, which introduce their own variability and safety considerations. Demonstrating that continuous-wave focused ultrasound can modulate tracer transport across a human endothelial monolayer without any added bubbles suggests that a simpler, bubble-free paradigm might deserve closer investigation, at least under controlled in vitro conditions.

The authors are equally clear about the limits of generalization. The hCMEC/D3 line, while human and reproducible, exhibits lower electrical resistance and higher paracellular permeability than primary or stem-cell-derived barrier models, and it lacks the pericytes, glial interactions, basement membrane, and hemodynamic environment of a real neurovascular barrier. The cells are of cerebral, not retinal, origin, so the findings cannot be assumed to translate directly to the blood-retinal barrier, even though the two share fundamental endothelial features. The study also did not measure transendothelial electrical resistance or junctional protein organization, leaving baseline barrier tightness and post-exposure recovery uncharacterized by orthogonal measures.

What the study does deliver is a methodological template. By treating the paired experiment as the biological unit, correcting cumulative transport calculations for both decreasing compartment volume and tracer removed during repeated sampling, and analyzing exposure and post-exposure intervals separately, the researchers have built a framework that other groups can adopt to disentangle when, not just whether, ultrasound affects endothelial transport. Future work, they suggest, should include randomized well positions, applicator-coupled sham controls, direct acoustic characterization near the monolayer, temperature monitoring, cavitation detection, time-resolved electrical resistance measurements, and replication in human retinal microvascular endothelial cells and more complex multicellular barrier models.

For now, the finding stands as a carefully bounded but genuinely novel observation: a short burst of continuous-wave focused ultrasound, delivered without microbubbles, measurably and reproducibly increased the passage of a small hydrophilic tracer across a human brain endothelial monolayer, and it did so predominantly while the sound was on. Whether that transient window of enhanced transport can be harnessed for drug delivery to the brain or retina, and whether it can be achieved without collateral cellular stress, remains an open and compelling question for the field.

Subject of Research: Focused ultrasound modulation of tracer transport across human cerebral endothelial monolayers in vitro

Article Title: Focused ultrasound increases Lucifer Yellow transport across hCMEC/D3 endothelial monolayers

Article References: Bleker, S., Redeker, K.-E. M., Meußler, G., Brinkmann, R., Brockmöller, J., & Russmann, C. (2026). Focused ultrasound increases Lucifer Yellow transport across hCMEC/D3 endothelial monolayers. Frontiers in Acoustics, 4, Article 1968185. https://doi.org/10.3389/facou.2026.1968185

Image Credits: AI Generated

DOI: 10.3389/facou.2026.1968185

Keywords: focused ultrasound, blood-brain barrier, hCMEC/D3, endothelial monolayer, Lucifer Yellow, drug delivery, microbubbles, in vitro model, acoustic bioeffects, blood-retinal barrier, paracellular transport, continuous-wave ultrasound